The U.S. Drug Enforcement Administration in July 2026 proposed temporarily designating 7-hydroxymitragynine (7-OH) above a certain potency threshold as a Schedule I controlled substance.

From the articleKratom and 7-OH should be regulated, experts agree. They’re split on how. - The Boston GlobeAlso in HHS endorses DEA move to schedule synthetic kratom extracts